Opportunity ID: 316063
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-19-GWIRP-IA |
Funding Opportunity Title: | DoD Gulf War Illness, Idea Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 3 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | May 16, 2019 |
Last Updated Date: | May 16, 2019 |
Original Closing Date for Applications: | Oct 03, 2019 |
Current Closing Date for Applications: | Oct 03, 2019 |
Archive Date: | Nov 02, 2019 |
Estimated Total Program Funding: | $800,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: |
Impact: Applications must articulate how results will lead to a clinical impact for Veterans with GWI even if a clinical impact is not an immediate outcome. All applications must focus on features of GWI and Veterans of the 1990-1991 Gulf War affected by GWI. It is the responsibility of the PI to clearly and explicitly articulate the project’s potential impact on GWI. FY19 GWIRP Idea Award Topics of Special Interest: The FY19 GWIRP Idea Award has a special interest in the exploration of the topics listed below. Elucidation of mechanisms outside the context of GWI is not within the scope of this funding opportunity. Applicants are not restricted to this list and may propose studies in any other GWI research area relevant to the mission of the GWIRP and in the context of the Overarching Challenges. • Epidemiology of comorbidities and mortality, including gender or ethnic differences, or sinus, respiratory, gastrointestinal, sleep, or dermatological abnormalities as a component of GWI • Interactions among individual symptoms of GWI, including non-refreshing sleep, and how these symptom clusters affect health outcomes and Veterans’ health overall • Genetic factors predisposing individuals to GWI • Molecular signatures (e.g., biomarkers) underlying symptom clusters via genomic, proteomic, metabolic, or epigenetic technologies • Dysregulation of, or abnormal crosstalk between, human body organ systems (e.g., neuroinflammation, autonomic dysfunction). Particular emphasis is placed on the systems listed below. Note: Examination of parameters at both baseline and after challenge (stress, exercise, immune, etc.) and attention to long-term and latent effects of toxicant exposures to closely represent the current status of GWI patients should be considered. ○ Neurological system (central, peripheral, autonomic, and/or neuromuscular) ○ Immune system ○ Endocrine, exocrine, and/or excretory systems, with special attention to kidney and liver (including Cytochrome P450 abnormalities)
|
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Packages
Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org Email: help@eBRAP.org |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
12.420 | PKG00251064 | May 16, 2019 | Oct 03, 2019 | View |